mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
8e-05 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-05 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.0007 |